Related Content
May 29, 2020 — Neovasc Inc., developer of a minimally invasive transcatheter mitral valve replacement (TMVR) ...
May 29, 2020
July 9, 2019 — Neovasc Inc. announced that its Tiara transcatheter mitral valve replacement (TMVR) device and its ...
July 09, 2019
December 7, 2016 — Boston Scientific announced a definitive agreement to acquire certain manufacturing assets and ...
December 07, 2016
May 24, 2016 — Edwards Lifesciences Corp. announced that a federal jury in Boston returned a verdict in favor of CardiAQ ...
May 24, 2016
Feature | Heart Valve Technology| Dave Fornell
(This article was updated in June 2018) The advent of transcatheter valve repair and replacement technologies is one of ...
November 12, 2015
January 28, 2015 — Neovasc Inc. has commenced a public offering in the United States of 8 million shares of the company ...
January 28, 2015
Feature | Heart Valve Technology| Dave Fornell
Now that transcatheter aortic valve replacement (TAVR) is rapidly becoming an established treatment option, cardiology ...
December 30, 2014October 16, 2014 - Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S ...
October 16, 2014July 8, 2014 — CardiAQ Valve Technologies (CardiAQ), a leader in the field of transcatheter mitral valve implantation ...
July 08, 2014
February 18, 2014 — Neovasc Inc. announced that a first-in-human implantation of its Tiara transcatheter mitral valve ...
February 18, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now